Concepedia

Publication | Closed Access

Risk of thromboembolism in patients with hereditary angioedema treated with plasma-derived C1-inhibitor

DOI

35

Citations

0

References

2016

Year

Henriette Farkas, Kinga Viktória Kőhalmi, Nóra Veszeli, Zsuzsanna Zotter, Katalin Várnai, Lilian Varga
Allergy and Asthma Proceedings

Abstract

Our cohort study did not find any evidence for an increased risk of thromboembolism during treatment with pdC1-INH, despite the presence of multiple predisposing factors.